Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials.
The company has finalized the Phase 3 clinical trial structure for its COVID-19 vaccine, Mrna-1273, after dosing its first patient back on 16 March in its Phase I trial.
Image caption: U.S. Air Force photo/Senior Airman Areca T. Wilson